In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track ...

Pfizer Inc. (NYSE: PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

Reviving UK investment is among the most pressing challenges facing Britain. Rachel Reeves plans to raise the issue in her ...

Activist investor Starboard Value disclosed a 9% stake in Tripadvisor on Thursday and said the stock was undervalued. Shares ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

The study will use a companion lipid biomarker test to identify those with a poor prognosis who are potential best responders.

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

On July 2, 2025, it was reported that Senator Ron L Wyden executed a sale of Pfizer PFE +0.24% Get Free Report stock, valued between $1,001 and $15,000. The transaction, recorded in the July filing, ...